Xenotransplantation: Gene-Edited Pig Liver Filter

A medical team at the University of Pennsylvania recently achieved a significant milestone in the field of xenotransplantation. By successfully connecting a gene-edited pig liver to a brain-dead human donor externally, they demonstrated that animal organs could potentially filter human blood without immediate rejection. This breakthrough offers new hope for patients suffering from acute liver failure who currently lack effective treatment options like kidney dialysis.

The UPenn Experiment: A 72-Hour Success

In early 2024, surgeons at the Perelman School of Medicine at the University of Pennsylvania performed a procedure known as extracorporeal perfusion. Unlike a standard transplant where the organ is placed inside the body, this procedure involved hooking up a pig liver outside the body of a brain-dead “decedent” model. The goal was to see if the pig liver could function as a biological filter for human blood.

The experiment was highly specific in its execution:

  • Duration: The study lasted for 72 hours.
  • Function: The pig liver successfully filtered blood, maintained stable pressure, and even produced bile, which is a key indicator of liver health.
  • Result: The human body did not reject the organ, and the liver did not sustain damage during the three-day period.

Dr. Abraham Shaked of the UPenn Transplant Institute led the study. He noted that the liver performed the complex chemical work required to sustain life, effectively acting as a bridge. This success suggests that in the future, doctors could use this method to keep a patient alive long enough to receive a human transplant or to allow their own damaged liver to regenerate.

The Science: eGenesis and Gene Editing

The liver used in this experiment was not an ordinary animal organ. It was provided by eGenesis, a biotechnology company based in Cambridge, Massachusetts. The company uses CRISPR-Cas9 technology to genetically modify pigs to make their organs compatible with human biology.

For this specific liver, eGenesis applied 69 distinct genomic edits. These edits serve three primary purposes:

  1. Removing “Glycan” Antigens: Pigs naturally have sugars on their cells that trigger an immediate, violent immune attack from the human body. These sugars were knocked out.
  2. Adding Human Genes: To help the human immune system recognize the organ as “self” rather than a foreign invader, the scientists inserted seven human genes that regulate inflammation and blood coagulation.
  3. Inactivating Retroviruses: Pigs carry Porcine Endogenous Retroviruses (PERVs) in their DNA. While harmless to pigs, these could theoretically jump to humans. The gene editing process inactivated these viruses to ensure safety.

This level of genetic engineering is crucial. Without these specific modifications, the human blood would have likely clotted immediately, and the liver would have been destroyed within minutes of connection.

Why We Need a "Liver Dialysis" Machine

This technology addresses a massive gap in modern medicine. When a patient suffers from kidney failure, they can go on dialysis. Machines filter the blood, removing toxins and excess fluid, keeping the patient alive for years.

There is no mechanical equivalent for the liver. The liver performs over 500 vital functions, including producing proteins, metabolizing drugs, and clotting blood. A mechanical filter cannot replicate these biological processes.

This is why the “bio-bridge” concept is so important. For patients with Acute Liver Failure (ALF), death can occur in days. By connecting a patient to an external gene-edited pig liver, doctors could:

  • Stabilize the patient: The pig liver takes over the metabolic load, reducing brain swelling and stabilizing blood chemistry.
  • Buy time: This stabilization allows time for a human donor liver to become available.
  • Enable self-healing: In some cases of acute poisoning or trauma, the patient’s own liver might heal if given a few days of rest. This external device provides that rest.

Ethical Considerations and Clinical Trials

The use of brain-dead donors, also called decedent models, has become a standard ethical pathway for testing xenotransplantation before moving to living patients. In this case, the family of the donor generously consented to the research, understanding that their loved one could contribute to saving future lives.

Following this successful 72-hour trial, the next steps involve rigor and regulation. The FDA requires extensive data before allowing trials on living patients. However, the UPenn team and eGenesis are gathering the necessary safety data to move toward a Phase 1 clinical trial.

If successful in living humans, this could transform critical care. Instead of waiting on a transplant list while their condition deteriorates, a patient could be hooked up to a pig liver in the ICU, buying the vital time needed for survival.

Frequently Asked Questions

Is this the same as the pig heart transplants? No, but it is related. The pig heart transplants performed at the University of Maryland were internal organ replacements. The UPenn liver experiment was extracorporeal, meaning the organ stayed outside the body and was connected via tubes, similar to a dialysis machine.

Why not just transplant the pig liver inside the human? Liver transplantation is surgically more complex than heart or kidney transplantation. The liver produces many proteins and enzymes that must be perfectly compatible with the human body. An external “bridge” is a safer first step to prove the liver can function and clean human blood without the risks of a full surgical transplant.

How long can the external pig liver work? The study at UPenn ran for 72 hours, which is often the critical window for patients with acute liver failure. Future studies may attempt to extend this duration to see how long the organ remains viable.

Are there risks of animal viruses infecting humans? This is a primary concern in xenotransplantation. To mitigate this, eGenesis used CRISPR to inactivate endogenous retroviruses in the pig’s DNA. Throughout the 72-hour experiment, researchers monitored for any signs of viral transmission and found none.